Evidence map›Paper›PMID 40453058›Full record

ArticleBlood neoplasia2024

Data-driven flow cytometry classification of blast differentiation in older patients with acute myeloid leukemia.

Catia Simoes, Carmen Gonzalez, François Vergez, Audrey Sarry, Sarah Bertoli, Beñat Ariceta, David Martínez-Cuadrón, Juan-Miguel Bergua, Susana Vives, Lorenzo Algarra and 25 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood neoplasia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Catia SimoesCancer Center Clinica Universidad de Navarra, CIMA Universidad de Navarra, IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain.
Carmen GonzalezCancer Center Clinica Universidad de Navarra, CIMA Universidad de Navarra, IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain.
François VergezLaboratoire d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
Audrey SarryService d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
Sarah BertoliUniversité Toulouse III Paul Sabatier, Toulouse, France.
Beñat AricetaCancer Center Clinica Universidad de Navarra, CIMA Universidad de Navarra, IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain.
David Martínez-CuadrónHospital Universitario y Politécnico La Fe, CIBER-ONC number CB16/12/00284, Valencia, Spain.
Juan-Miguel BerguaHospital San Pedro de Alcántara, Cáceres, Spain.
Susana VivesHospital Germans Trias i Pujol, Badalona, Spain.
Lorenzo AlgarraHospital General de Albacete, Albacete, Spain.
Mar TormoHospital Clínico Universitario, Universidad de Valencia, Instituto de investigación INCLIVA, Valencia, Spain.
Pilar MartinezHospital Universitario 12 de Octubre, I+12, CNIO, Complutense University, CIBERONC, Madrid, Spain.
Josefina SerranoHospital Universitario Reina Sofía, IMIBIC, Córdoba, Spain.
Pilar HerreraHospital Universitario Ramón y Cajal, Madrid, Spain.
Fernando RamosHospital Universitario de León, Léon, Spain.
Olga SalameroHospital Universitario Vall d'Hebrón, Barcelona, Spain.
Esperanza LavillaHospital Universitario Lucus Augusti, Lugo, Spain.
Cristina GilHospital General Universitario de Alicante, Alicante, Spain.
Jose-Luis Lopez-LorenzoHospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
Maria-Belen VidrialesHospital Universitario de Salamanca, IBSAL, CIBER-ONC number CB16/12/00233 y Centro de Investigación, Salamanca, Spain.
Carmen ChillonHospital Universitario de Salamanca, IBSAL, CIBER-ONC number CB16/12/00233 y Centro de Investigación, Salamanca, Spain.
Jorge LabradorHospital Universitario de Burgos, Universidad Isabel I, Burgos, Spain.
Jose-Francisco FalantesComplejo Hospitalario Virgen del Rocío, Seville, Spain.
María-José SayasHospital Dr. Peset, Valencia, Spain.
Rosa AyalaHospital Universitario 12 de Octubre, I+12, CNIO, Complutense University, CIBERONC, Madrid, Spain.
Joaquin Martinez-LopezHospital Universitario 12 de Octubre, I+12, CNIO, Complutense University, CIBERONC, Madrid, Spain.
Sara VillarCancer Center Clinica Universidad de Navarra, CIMA Universidad de Navarra, IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain.
Maria-Jose CalasanzCancer Center Clinica Universidad de Navarra, CIMA Universidad de Navarra, IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain.
Felipe ProsperCancer Center Clinica Universidad de Navarra, CIMA Universidad de Navarra, IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain.
Jesús F San-MiguelCancer Center Clinica Universidad de Navarra, CIMA Universidad de Navarra, IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain.
Miguel Á SanzHospital Universitario y Politécnico La Fe, CIBER-ONC number CB16/12/00284, Valencia, Spain.
Christian RécherUniversité Toulouse III Paul Sabatier, Toulouse, France.
Bruno PaivaCancer Center Clinica Universidad de Navarra, CIMA Universidad de Navarra, IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain.
Pau MontesinosHospital Universitario y Politécnico La Fe, CIBER-ONC number CB16/12/00284, Valencia, Spain.
PETHEMA Cooperative Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40453058
PMCPMC12082131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.